Advertisement

Naunyn-Schmiedeberg's Archives of Pharmacology

, Volume 287, Issue 4, pp 329–347 | Cite as

Influence of glyceryl trinitrate on force of contraction and action potential of guinea-pig myocardium

  • M. Korth
Article

Summary

  1. 1.

    The inotropic effect of glyceryl trinitrate (GTN) was studied in guinea-pig papillary muscles and atrial strips by analysing the isometric contraction curve and the monophasic action potential (AP).

     
  2. 2.

    GTN, 7\sx10\t-5 M, reduced the force of contraction by 10%; increases in contractile force appeared at 2\sx10\t-4 M in papillary muscles and at 1.4\sx10\t-4 M in atrial strips. The maximum of the contractile force was reached in both preparations at 5\sx10\t-4 M GTN. Positive inotropic effects were transitory (3\2-5 min) and were followed by marked negative inotropic effects.

     
  3. 3.

    In the presence of GTN, only 15 of 26 papillary muscles showed a positive inotropic response and there was a great variance in its intensity. Prior exposure of papillary muscles to a low GTN concentration, which by itself reduced force of contraction (like every single GTN application), was the prerequisite for the positive inotropic effect of a subsequent higher GTN concentration.

    In atrial strips the positive inotropic action was consistent and uniform. The maximum force of contraction in response to single applications of GTN was only about 50% of that in response to cumulatively increased GTN concentrations.

     
  4. 4.

    In the presence of 5\sx10\t-4 M GTN, the tyramine concentration-effect curve was shifted to the left (by one log unit at the ED50 level).

     
  5. 5.

    -Adrenoceptor blockade by (\+-)-propranolol (5\sx10\t-6 M) or noradrenaline depletion by pretreatment of the animals with reserpine (5 mg/kg, 18\2-22 hrs prior to the experiment) prevented the positive inotropic effects of GTN in both preparations. Hence, the GTN-induced increase in contractile force is induced by the liberation of noradrenaline and an inhibitory effect on the monoamine oxidase (MAO) of sympathetic nerve endings might be involved.

     
  6. 6.

    In atrial preparations exposed to 5\sx10\t-4 M GTN, time to peak force (t1) and relaxation time (t2) were shortened by 12% and 33%, respectively. Pretreatment of the animals with reserpine prevented the shortening of t1 and changed the shortening of t2 from 33% to 19%.

     
  7. 7.

    In papillary muscles, 5\sx10\t-4 M GTN shortened t1 by 10%, while t2 was prolonged by 17% in noradrenaline-depleted, and by 36% in control muscles. Prolongation of t2 at 5\sx10\t-4 M GTN was accompanied by an increase in the duration of the monophasic action potential (AP) in reserpine-pretreated as well as in control muscles by 12% and 26%, respectively (measured at 90% repolarization). The same GTN concentration slowed the maximum rate of depolarisation by 32%. After 35 min the AP returned to approximately the control value. In the presence of 5\sx10\t-4 M GTN, noradrenaline (1\sx10\t-5 M) lengthened the AP by 38% in both, control muscles and noradrenaline-depleted preparations.

     

Key words

Glyceryl Trinitrate Negative Inotropic Effect Indirect Sympathomimetic Effect Relaxation Time Cardiac Muscle 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Angelakos, E. T., Fuxe, K., Torchiana, M. L.: Chemical and histochemical evaluation of the distribution of catecholamines in the rabbit and guinea-pig hearts. Acta physiol. scand. 59, 184–192 (1963)Google Scholar
  2. Blaschko, H., Richter, D., Schlossmann, H.: The oxidation of adrenaline and other amines. Biochem. J. 31, 2187–2196 (1937)Google Scholar
  3. Blum, S. W., Quinn, J. B., Howe, B. B., Hefner, M. A., Winbury, m. M.: Pharmacologic and biochemical evaluation of organic nitrates: Attempted correlation of activities. J. Pharmacol. exp. Ther. 176, 684–691 (1971)Google Scholar
  4. Brandt, W., Reiter, M., Seibel, K.: A postsynaptic effect of tyramine in ventricular muscle. Naunyn-Schmiedeberg's Arch. Pharmacol. 273, 283–293 (1972)Google Scholar
  5. Cervoni, P., Kirpekar, S. M., Schwab, A.: The effect of drugs on uptake and release of catecholamines in the isolated left atrium of the guinea pig. J. Pharmacol. exp. Ther. 151, 196–206 (1966)Google Scholar
  6. Charlier, R.: Antianginal drugs. Pathophysiological, haemodynamic, methodological, pharmacological, biochemical and clinical basis for their use in human therapeutics. In: Handbook of Experimental Pharmacology, vol. XXXI, pp. 120–128 (1971)Google Scholar
  7. Furchgott, R. F., de Gubareff, T., Grossman, A.: Release of autonomic mediators in cardiac tissue by suprathreshold stimulation. Science 129, 328–329 (1959)Google Scholar
  8. Hashimoto, K., Taira, N., Chiba, S., Hashimoto jr., K., Endoh, M., Kokubun, M., Kokubun, H., Iijima, T., Kimura, T., Kubota, K., Oguro, K.: Cardiohemodynamic effects of BAY a 1040 in dog. Arzneimittel-Forsch. (Drug Res.) 22, 15–21 (1972)Google Scholar
  9. Kalin, M., Kylin, B.: Organic nitrate explosives as monoamine oxidase inhibitors. Arch. environm. Hlth. 18, 311–314 (1969)Google Scholar
  10. Koch-Weser, J.: Effect of rate changes on strength and time course of contraction of papillary muscle. Amer. J. Physiol. 204, 451–457 (1963)Google Scholar
  11. Korth, M.: Inotropic effects of glyceryl trinitrate on the isolated guinea-pig myocardium. Naunyn-Schmiedeberg's Arch. Pharmacol. 282, R50 (1974)Google Scholar
  12. Lesch, M., Gorlin, R.: Pharmacological therapy of angina pectoris. Mod. Conc. cardiov. Dis. 42, 5–10 (1973)Google Scholar
  13. Muscholl, E.: Die Konzentration von Noradrenalin und Adrenalin in den einzelnen Abschnitten des Herzens. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 237, 350–364 (1959)Google Scholar
  14. Ogawa, K., Gudbjarnason, S., Bing, R. J.: Nitroglycerin (Glyceryl Trinitrate) as a monoamine oxidase inhibitor. J. Pharmacol. exp. Ther. 155, 449–455 (1967)Google Scholar
  15. Ogawa, K., Gudbjarnason, S.: A correlation between the inhibition of monoamine oxidase activity and the relief of angina pain by organic nitrates. Arch. int. Pharmacodyn. 1, 172–182 (1968)Google Scholar
  16. Quadbeck, J., Reiter, M.: Cardiac action potential and inotropic effect of noradrenaline and calcium. Naunyn-Schmiedeberg's Arch. Pharmacol. 286, 337–351 (1975)Google Scholar
  17. Raff, W. K., Drechsel, U., Scholtholt, J., Lochner, W.: Herzwirkung des Nitroglycerins. Pflügers Arch. 317, 336–343 (1970)Google Scholar
  18. Reiter, M.: Die Wertbestimmung inotrop wirkender Arzneimittel am isolierten Papillarmuskel. Arzneimittel-Forsch. (Drug Res.) 17, 1249–1253 (1967)Google Scholar
  19. Reiter, M.: Drugs and heart muscle. Ann. Rev. Pharmacol. 12, 111–124 (1972)Google Scholar
  20. Robin, E., Cowan, C., Puri, P., Ganguly, S., Deboyrie, E., Martinez, M., Stock, T., Bing, R. J.: A comparative study of nitroglycerin and propranolol. Circulation 36, 175–186 (1967)Google Scholar
  21. Shore, P. A., Cohn jr., V. H., Highman, B., Maling, H. M.: Distribution of norepinephrine in the heart. Nature (Lond.) 181, 848 (1958)Google Scholar
  22. Smith, C. B.: The role of monoamine oxidase in the intraneuronal metabolism of norepinephrine released by indirectly acting sympathomimetic amines or by adrenergic nerve stimulation. J. Pharmacol. exp. Ther. 151, 207–220 (1966)Google Scholar
  23. Strauer, B. E., Westberg, C., Tauchert, M.: Untersuchungen über inotrope Nitroglycerinwirkungen am isolierten Ventrikelmyokard. Pflügers Arch. 324, 124–133 (1971)Google Scholar
  24. Trendelenburg, U.: Modification of the effect of tyramine by various agents and procedures. J. Pharmacol. exp. Ther. 134, 8–17 (1961)Google Scholar
  25. Vassort, G., Rougier, O., Garnier, D., Sauviat, M. P., Coraboeuf, E., Gargouil, Y. M.: Effects of adrenaline on membrane inward currents during the cardiac action potential. Pflügers Arch. 307, 70–81 (1969)Google Scholar
  26. Vater, W., Kroneberg, G., Hoffmeister, F., Kaller, H., Meng, K., Oberdorf, A., Puls, W., Schlossmann, K., Stoepel, K.: Zur Pharmakologie von 4-(2-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsäuredimethylester (Nifedipine) BAY a 1040. Arzneimittel-Forsch. (Drug Res.) 22, 1–14 (1972)Google Scholar
  27. Waldeck, B.: Failure to demonstrate monoamine oxidase inhibition by glyceryl trinitrate in vivo. Acta pharmacol. (Kbh.) 28, 406–412 (1970)Google Scholar
  28. Weidmann, S.: The effect of the cardiac membrane potential on the rapid availability of the sodium-carrying system. J. Physiol. (Lond.) 127, 213–224 (1955)Google Scholar
  29. Wiener, L., Dwyer jr. E. M., Cox, J. W.: Hemodynamic effects of nitroglycerin, propranolol, and their combination in coronary heart disease. Circulation 39, 623–632 (1969)Google Scholar
  30. Wurtman, R. J., Axelrod, J.: A sensitive assay for the estimation of monoamine oxidase. Biochem. Pharmacol. 12, 1439–1441 (1963)Google Scholar

Copyright information

© Springer-Verlag 1975

Authors and Affiliations

  • M. Korth
    • 1
    • 2
  1. 1.Institut für Pharmakologie und Toxikologie der TechnischenUniversität MünchenMünchen 40Germany
  2. 2.Abteilung für experimentelle Pharmakologie der Gesellschaft für Strahlen-und UmweltforschungMünchen

Personalised recommendations